BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma
Human Pathology May 17, 2018
Lee HE, et al. - The prevalence of BRCA1-associated protein 1 (BAP1) loss in well-differentiated papillary mesothelioma (WDPM) by immunohistochemistry with clinical correlation, along with CDKN2A deletion status by fluorescence in situ hybridization (FISH) was investigated in this study. Researchers identified eight patients diagnosed as WDPM from the surgical pathology file. They reported that WDPM did not show CDKN2A deletion in any case. They observed that BAP1 loss was also absent in all pure WDPM cases though was identified in all WDPM with synchronous or metachronous MM. Data showed that similar genetic landscape in WDPM and MM components suggested their clonal relationship.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries